See how this trading course helps small investors earns Extra Income. Download Free Today. Here's how ordinary people are earning $5,000 - $20,000 each month in their spare time
Search results
- "Overall, this new wrinkle would seem to give Amedisys options should it have regrets about its original deal," Oppenheimer analyst Michael Wiederhorn said. Amedisys will have to pay Option $106 million if it terminates their agreement.
www.reuters.com/markets/deals/amedisys-gets-over-3-billion-unsolicited-offer-unitedhealths-optum-2023-06-05/UnitedHealth offers over $3 billion for home health firm Amedisys
People also ask
What happened to Amedisys?
Will Amedisys have options if it regrets its original deal?
Will UnitedHealth buy Amedisys?
How much will Amedisys pay option?
Will Optum buy Amedisys?
Will Amedisys deal face antitrust scrutiny?
Jul 11, 2024 · About a year ago, UnitedHealth Group’s Optum announced that it plans to acquire home care company Amedisys for about $3.3 billion, beating out Option Care Health. The deal would be an all-cash...
Jun 26, 2023 · June 26 (Reuters) - Home health and hospice caregiver Amedisys (AMED.O) on Monday agreed to a $3.3 billion sweetened cash offer from UnitedHealth Group (UNH.N) and scrapped an all-stock deal...
Jul 1, 2024 · UnitedHealth's Optum unit said it would buy Amedisys in an all-cash deal for $101 per share. Media reports have pegged the deal value at $3.3 billion.
- Heather Landi
Jun 5, 2024 · In a fragmented home health industry, over 100 locations changing ownership is no small deal. If the Optum-Amedisys deal is completed, Optum will become the largest provider of home health care with just about 10% of the market underneath its belt. The divestment will likely decrease Amedisys’ footprint by about 20%.
- Andrew Donlan
Sep 11, 2023 · Amedisys agreed to the deal with Option Care in May, and the infusion therapy provider will receive a $106 million termination fee. In mid-August, Amedisys disclosed in a filing that the...
Jun 26, 2023 · Amedisys will pay Option $106 million to terminate their agreement, according to a Monday filing with the SEC. Option, a provider of home and alternate site infusion services, is unlikely...